MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1056/nejmoa1808424

Медицинская библиотека · The New England journal of medicine · 2019

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

Harter Philipp, Sehouli Jalid, Lorusso Domenica, Reuss Alexander, Vergote Ignace, Marth Christian, Kim Jae-Weon, Raspagliesi Francesco, Lampe Björn, Aletti Giovanni, Meier Werner, Cibula David, Mustea Alexander, Mahner Sven, Runnebaum Ingo B, Schmalfeldt Barbara, Burges Alexander, Kimmig Rainer, Scambia Giovanni, Greggi Stefano, Hilpert Felix, Hasenburg Annette, Hillemanns Peter, Giorda Giorgio, von Leffern Ingo, Schade-Brittinger Carmen, Wagner Uwe, du Bois Andreas

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Systematic pelvic and paraaortic lymphadenectomy has been widely used in the surgical treatment of patients with advanced ovarian cancer, although supporting evidence from randomized clinical trials has been limited.

METHODS

We intraoperatively randomly assigned patients with newly diagnosed advanced ovarian cancer (International Federation of Gynecology and Obstetrics stage IIB through IV) who had undergone macroscopically complete resection and had normal lymph nodes both before and during surgery to either undergo or not undergo lymphadenectomy. All centers had to qualify with regard to surgical skills before participation in the trial. The primary end point was overall survival.

RESULTS

A total of 647 patients underwent randomization from December 2008 through January 2012, were assigned to undergo lymphadenectomy (323 patients) or not undergo lymphadenectomy (324), and were included in the analysis. Among patients who underwent lymphadenectomy, the median number of removed nodes was 57 (35 pelvic and 22 paraaortic nodes). The median overall survival was 69.2 months in the no-lymphadenectomy group and 65.5 months in the lymphadenectomy group (hazard ratio for death in the lymphadenectomy group, 1.06; 95% confidence interval [CI], 0.83 to 1.34; P = 0.65), and median progression-free survival was 25.5 months in both groups (hazard ratio for progression or death in the lymphadenectomy group, 1.11; 95% CI, 0.92 to 1.34; P = 0.29). Serious postoperative complications occurred more frequently in the lymphadenectomy group (e.g., incidence of repeat laparotomy, 12.4% vs. 6.5% [P = 0.01]; mortality within 60 days after surgery, 3.1% vs. 0.9% [P = 0.049]).

CONCLUSIONS

Systematic pelvic and paraaortic lymphadenectomy in patients with advanced ovarian cancer who had undergone intraabdominal macroscopically complete resection and had normal lymph nodes both before and during surgery was not associated with longer overall or progression-free survival than no lymphadenectomy and was associated with a higher incidence of postoperative complications. (Funded by Deutsche Forschungsgemeinschaft and the Austrian Science Fund; LION ClinicalTrials.gov number, NCT00712218.).

Для цитирования: Harter Philipp, Sehouli Jalid, Lorusso Domenica, Reuss Alexander, Vergote Ignace, Marth Christian, Kim Jae-Weon, Raspagliesi Francesco, Lampe Björn, Aletti Giovanni, Meier Werner, Cibula David, Mustea Alexander, Mahner Sven, Runnebaum Ingo B, Schmalfeldt Barbara, Burges Alexander, Kimmig Rainer, Scambia Giovanni, Greggi Stefano, Hilpert Felix, Hasenburg Annette, Hillemanns Peter, Giorda Giorgio, von Leffern Ingo, Schade-Brittinger Carmen, Wagner Uwe, du Bois Andreas. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.. The New England journal of medicine. 2019. DOI: 10.1056/nejmoa1808424.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.